Leap Therapeutics (LPTX) Stock Chart & Stock Price History → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free LPTX Stock Alerts $3.19 +0.02 (+0.63%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Leap Therapeutics Stock Price Performance5 Day Performance+2.90%1 Month Performance+25.59%3 Month Performance-6.18%6 Month Performance+76.24%Year-To-Date Performance-23.04%1 Year Performance-17.97% Receive LPTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. LPTX Stock Chart for Sunday, May, 5, 2024 LPTX Chart by TradingView Leap Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$3.17$3.19+0.63%$3.28$3.01334,593 shs$81.66 million05/02/2024$3.27$3.17-3.06%$3.31$3.05137,305 shs$81.15 million05/01/2024$3.10$3.27+5.48%$3.29$3.12151,393 shs$83.71 million04/30/2024$3.07$3.10+0.98%$3.27$3.02105,872 shs$79.36 million04/29/2024$3.25$3.07-5.54%$3.40$3.03130,337 shs$78.59 million04/26/2024$3.17$3.25+2.52%$3.39$2.99403,126 shs$83.20 million Get the Latest News and Ratings for LPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$3.29$3.17-3.65%$3.29$3.12212,832 shs$81.15 million04/24/2024$3.20$3.29+2.81%$3.30$3.10200,195 shs$84.22 million04/23/2024$3.21$3.20-0.31%$3.33$3.1089,131 shs$81.92 million04/22/2024$2.80$3.21+14.64%$3.26$2.85328,679 shs$82.18 million04/19/2024$2.96$2.80-5.41%$3.04$2.77211,020 shs$71.68 million04/18/2024$3.00$2.96-1.33%$3.03$2.89101,757 shs$75.78 million04/17/2024$2.98$3.00+0.67%$3.14$2.92146,417 shs$76.80 million04/16/2024$3.00$2.98-0.67%$3.20$2.95151,106 shs$76.29 million04/15/2024$3.24$3.00-7.41%$3.49$2.75521,737 shs$76.80 million04/12/2024$3.12$3.24+4.01%$3.50$3.07565,216 shs$82.94 million04/11/2024$3.04$3.12+2.47%$4.39$3.035.67 million shs$79.74 million04/10/2024$3.41$3.04-10.85%$3.38$2.91435,581 shs$87.30 million04/09/2024$2.58$3.41+32.17%$3.59$2.591.35 million shs$87.30 million04/08/2024$2.54$2.58+1.57%$2.64$2.5368,225 shs$66.05 million04/05/2024$2.51$2.54+1.20%$2.57$2.4567,326 shs$65.02 million04/04/2024$2.53$2.51-0.79%$2.65$2.4293,873 shs$64.26 million04/03/2024$2.63$2.53-3.80%$2.60$2.42127,003 shs$64.77 million04/02/2024$2.75$2.63-4.36%$2.75$2.5883,945 shs$67.33 million04/01/2024$2.66$2.75+3.38%$2.75$2.55153,631 shs$70.40 million03/29/2024$2.66$2.66$2.98$2.65192,513 shs$68.10 million03/28/2024$2.78$2.66-4.32%$2.98$2.65192,342 shs$68.10 million03/27/2024$2.48$2.78+12.10%$2.81$2.44191,744 shs$71.17 million03/26/2024$2.40$2.48+3.33%$2.51$2.41101,108 shs$63.49 million03/25/2024$2.52$2.40-4.76%$2.52$2.32276,898 shs$61.44 million03/22/2024$2.55$2.52-1.18%$2.63$2.46107,881 shs$64.51 million03/21/2024$2.55$2.55$2.75$2.47289,272 shs$65.28 million03/20/2024$2.20$2.55+15.91%$2.63$2.21157,229 shs$65.20 million03/19/2024$2.14$2.20+2.80%$2.44$2.17317,462 shs$56.25 million03/18/2024$2.21$2.14-3.17%$2.24$2.13145,440 shs$54.72 million03/15/2024$2.20$2.21+0.45%$2.33$2.17149,477 shs$56.51 million03/14/2024$2.29$2.20-3.93%$2.34$2.14129,241 shs$56.25 million03/13/2024$2.50$2.29-8.40%$2.59$2.19255,922 shs$58.56 million03/12/2024$2.48$2.50+0.81%$2.54$2.4388,843 shs$63.93 million03/11/2024$2.50$2.48-0.80%$2.64$2.42215,702 shs$63.41 millionStock-Picking AI Predicts #1 Stock of 2024 (Ad)Since the start of the year, the top 10 investment funds in the world – including Vanguard, Blackrock, Fidelity and JP Morgan – have made nearly $1 trillion in profits on these 7 stocks.Click here to learn what's coming (and how to prepare).03/08/2024$2.38$2.50+5.04%$2.57$2.37116,249 shs$63.93 million03/07/2024$2.36$2.38+0.85%$2.50$2.36138,266 shs$60.86 million03/06/2024$2.60$2.36-9.23%$2.68$2.32231,674 shs$60.35 million03/05/2024$2.69$2.60-3.35%$2.75$2.53279,441 shs$66.48 million03/04/2024$2.83$2.69-4.95%$2.95$2.60217,156 shs$68.78 million03/01/2024$2.79$2.83+1.43%$3.00$2.82221,591 shs$72.36 million02/29/2024$2.85$2.79-2.11%$3.00$2.79287,845 shs$71.34 million02/28/2024$2.90$2.85-1.72%$3.04$2.80280,626 shs$72.87 million02/27/2024$3.00$2.90-3.17%$3.13$2.85334,985 shs$74.15 million02/26/2024$2.97$3.00+0.84%$3.19$2.98119,432 shs$76.57 million02/23/2024$2.99$2.97-0.67%$3.04$2.8976,222 shs$75.94 million02/22/2024$3.01$2.99-0.66%$3.12$2.92227,819 shs$76.44 million02/21/2024$3.10$3.01-2.75%$3.21$2.93134,668 shs$76.97 million02/20/2024$3.13$3.10-1.12%$3.25$3.00108,698 shs$79.14 million02/19/2024$3.13$3.13$3.30$2.93302,000 shs$80.03 million02/16/2024$3.27$3.13-4.28%$3.27$2.93301,969 shs$80.03 million02/15/2024$3.44$3.27-4.94%$3.63$3.20295,982 shs$83.61 million02/14/2024$3.12$3.44+10.26%$3.44$3.06170,644 shs$87.96 million02/13/2024$2.98$3.12+4.70%$3.16$2.8678,939 shs$79.78 million02/12/2024$3.24$2.98-8.02%$3.32$2.95189,773 shs$76.20 million02/09/2024$3.45$3.24-5.95%$3.51$3.13187,665 shs$82.85 million02/08/2024$3.50$3.45-1.57%$3.55$3.29146,382 shs$88.09 million02/07/2024$3.44$3.50+1.74%$3.71$3.26185,254 shs$89.50 million02/06/2024$3.40$3.44+1.18%$3.58$3.11256,353 shs$87.96 million02/05/2024$3.36$3.40+1.19%$3.54$3.26430,061 shs$86.94 million Related Companies: Vaccitech Stock Price Chart Barinthus Biotherapeutics Stock Price Chart LifeVantage Stock Price Chart BeyondSpring Stock Price Chart InflaRx Stock Price Chart Marinus Pharmaceuticals Stock Price Chart Affimed Stock Price Chart Aileron Therapeutics Stock Price Chart Tempest Therapeutics Stock Price Chart Connect Biopharma Stock Price Chart Receive LPTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LPTX) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leap Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.